James L. Drinkwater - Head of GMP Compliance at F Ziel GmbH

Aseptic containment strategies to meet challenges of processing new highly toxic and biologically hazardous sterile medicinal products and therapies

7 March 2019 | By Dr Holger Kranenburg - containment lead at Franz Ziel GmbH, James L. Drinkwater - Head of GMP Compliance at F Ziel GmbH

Active pharmaceutical ingredients (APIs) have been established in the pharmaceutical industry over the course of many years. Containment technologies – ie, those strategies developed to contain the APIs – and qualification practices based on API powder containment have primarily been based on health and safety issues related to operator exposure…